148 related articles for article (PubMed ID: 3778116)
21. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
22. Tumor cell-specific transcription of a murine histocompatibility class Ib Q5 gene.
Noguchi K; Kuwada E; Goto S; Egawa K
Anticancer Res; 2004; 24(5C):3379-86. PubMed ID: 15515435
[TBL] [Abstract][Full Text] [Related]
23. In vivo reexpression of H-2 antigens in B16 melanoma cells.
Lollini PL; Colombo MP; De Giovanni C; Nicoletti G; Parmiani G; Prodi G; Nanni P
Exp Clin Immunogenet; 1985; 2(1):14-23. PubMed ID: 3939971
[TBL] [Abstract][Full Text] [Related]
24. Transplantability and MHC antigen expression of tumor mast cells.
Nagata N; Saito T; Toki J; Ikehara S
Exp Toxicol Pathol; 1993 Feb; 45(1):29-34. PubMed ID: 8467197
[TBL] [Abstract][Full Text] [Related]
25. Studies on cell surface antigens of mouse leukemic and normal lymphocytes. II. Relationships between mammary leukemia, gross virus related and major histocompatibility antigens on L1210 leukemic lymphocytes.
Steuden J; Strzadała L; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):95-7. PubMed ID: 219815
[TBL] [Abstract][Full Text] [Related]
26. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
Green WR; Nowinski RC; Henney CS
J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
[No Abstract] [Full Text] [Related]
27. Independent control of the expression of several membrane-associated antigens of murine leukemia cells: metabolism and response to specific antiserum.
Cohen EP; Liang W
Prog Clin Biol Res; 1976; 9():89-99. PubMed ID: 1030806
[TBL] [Abstract][Full Text] [Related]
28. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
Weinhold KJ; Wheelock EF
Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
[TBL] [Abstract][Full Text] [Related]
29. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
Henderson LA; Ciavarra R; Riblet R; Forman J
J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
[TBL] [Abstract][Full Text] [Related]
30. Cell surface antigen phenotypes of MCF-induced thymic lymphomas in AKR mice.
Yetter RA; Morse HC
J Immunol; 1984 May; 132(5):2644-8. PubMed ID: 6609203
[TBL] [Abstract][Full Text] [Related]
31. Serologic and immunochemical studies of the cell membrane alloantigens of K36, an AKR spontaneous leukemia.
Schmidt W; Festenstein H; Atfield G
Transplant Proc; 1980 Mar; 12(1):29-31. PubMed ID: 7368291
[No Abstract] [Full Text] [Related]
32. Further molecular and functional evidence for the expression of H-2 allodeterminants on the AKR leukemia, K36.
Festenstein H; Alonzo AD; Ferluga J; Ma BL; Santamaria M; Marelli O; Schmidt W; Flavell RA
Transplant Proc; 1983 Dec; 15(4):2107-10. PubMed ID: 6200978
[No Abstract] [Full Text] [Related]
33. H-2K and H-2D antigens are independently regulated in mouse embryo fibroblasts.
King NJ; Sinickas VG; Blanden RV
Exp Clin Immunogenet; 1985; 2(4):206-14. PubMed ID: 3917150
[TBL] [Abstract][Full Text] [Related]
34. Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1.
Kuribayashi K; Keyaki A; Sakaguchi S; Masuda T
Immunology; 1985 Sep; 56(1):127-40. PubMed ID: 3876271
[TBL] [Abstract][Full Text] [Related]
35. [Humoral autoimmune reactions directed against autoantigens of the H-2 histocompatibility system in mice with developing Rauscher leukemia].
Ter-Griggorov VS; Moskovkina OIa; Krupnik VE; Graf IA; Pivnik AV
Eksp Onkol; 1988; 10(6):21-5. PubMed ID: 2468468
[TBL] [Abstract][Full Text] [Related]
36. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication.
Bhattacharya A; Dorf ME; Springer TA
J Immunol; 1981 Dec; 127(6):2488-95. PubMed ID: 6170707
[TBL] [Abstract][Full Text] [Related]
37. Immunogenetic studies of H-2 antigens of MCG 3 tumour cells.
Torres MD; Gutiérrez F; Rueda G; Osorio C
Rev Esp Fisiol; 1981 Jun; 37(2):173-6. PubMed ID: 7313274
[TBL] [Abstract][Full Text] [Related]
38. Metastatic capacity of cloned T10 sarcoma cells that differ in H-2 expression: inverse relationship to their immunogenic potency.
Katzav S; Segal S; Feldman M
J Natl Cancer Inst; 1985 Aug; 75(2):307-18. PubMed ID: 3894752
[TBL] [Abstract][Full Text] [Related]
39. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
Zola H
Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
[TBL] [Abstract][Full Text] [Related]
40. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
